Pancreatic cancer is the most lethal cancer with nearly every patient diagnosed dying within the ensuing 12 months. Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2030.1 Very rarely anecdotal reports on long-term survivors surface; however, such reports are becoming more common as new chemotherapeutic regimens have become used. However, long-term survivors (LTSs) (surviving ≥10 years) even with surgery are still rare, with a rate of only 6% at our institution: a tertiary center providing multidisciplinary treatment. Others2,3 have found similar long-term survival rates.
Xu M, Hines OJ. Long-term Survival After Pancreatic Cancer: Hope Has Arrived. JAMA Surg. 2015;150(8):710–711. doi:10.1001/jamasurg.2015.0702
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.